Precision medicine for ovarian clear cell carcinoma based on gene alterations
Author:
Funder
National Cancer Center Research and Development Grant
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Hematology,General Medicine,Surgery
Link
http://link.springer.com/content/pdf/10.1007/s10147-020-01622-z.pdf
Reference55 articles.
1. Jang JYA, Yanaihara N, Pujade-Lauraine E et al (2017) Update on rare epithelial ovarian cancers: based on the rare ovarian tumors young investigator conference. J Gynecol Oncol 28(4):e54
2. Okamoto A, Glasspool RM, Mabuchi S et al (2014) Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the ovary. Int J Gynecol Cancer 24(9 Suppl 3):S20–S25
3. Kobel M, Kalloger SE, Huntsman DG et al (2010) Differences in tumor type in low-stage versus high-stage ovarian carcinomas. Int J Gynecol Pathol 29(3):203–211
4. Yamagami W, Nagase S, Takahashi F et al (2017) Clinical statistics of gynecologic cancers in Japan. J Gynecol Oncol 28(2):e32
5. Bookman MA, Okamoto A, Stuart G et al (2017) Harmonising clinical trials within the Gynecologic Cancer InterGroup: consensus and unmet needs from the fifth ovarian cancer consensus conference. Ann Oncol 28(suppl_8):viii30–viii35
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A Novel ex-vivo platform for personalized treatment in metastatic ovarian cancer;2024-03-16
2. From clinical management to personalized medicine: novel therapeutic approaches for ovarian clear cell cancer;Journal of Ovarian Research;2024-02-12
3. Therapeutic Role of Synthetic Lethality in ARID1A-Deficient Malignancies;Journal of Immunotherapy and Precision Oncology;2024-02-01
4. Next-Generation Sequencing Reveals a Very Low Prevalence of Deleterious Mutations of Homologous Recombination Repair Genes and Homologous Recombination Deficiency in Ovarian Clear Cell Carcinoma;Frontiers in Oncology;2022-01-12
5. The Role of ARID1A in Tumors: Tumor Initiation or Tumor Suppression?;Frontiers in Oncology;2021-10-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3